# Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours

> **NCT03315091** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 31 (actual)

## Conditions studied

- Solid Tumours

## Interventions

- **DRUG:** Treatment A - AZD1775 administered under fasted conditions
- **DRUG:** Treatment B - AZD1775 administered under fed conditions.

## Key facts

- **NCT ID:** NCT03315091
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-29
- **Primary completion:** 2018-04-05
- **Final completion:** 2018-04-05
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03315091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03315091, "Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03315091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*